252 related articles for article (PubMed ID: 21047210)
1. Mesenchymal stem cells contribute to the abnormal bone marrow microenvironment in patients with chronic idiopathic neutropenia by overproduction of transforming growth factor-β1.
Stavroulaki E; Kastrinaki MC; Pontikoglou C; Eliopoulos D; Damianaki A; Mavroudi I; Pyrovolaki K; Katonis P; Papadaki HA
Stem Cells Dev; 2011 Aug; 20(8):1309-18. PubMed ID: 21047210
[TBL] [Abstract][Full Text] [Related]
2. The -509C/T polymorphism of transforming growth factor-beta1 is associated with increased risk for development of chronic idiopathic neutropenia.
Eliopoulos DG; Mavroudi I; Pontikoglou C; Ximeri M; Stavroulaki E; Pyrovolaki K; Velegraki M; Spanoudakis M; Goulielmos G; Papadaki HA
Eur J Haematol; 2009 Dec; 83(6):535-40. PubMed ID: 19614955
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta1 affects interleukin-10 production in the bone marrow of patients with chronic idiopathic neutropenia.
Pyrovolaki K; Mavroudi I; Papadantonakis N; Velegraki M; Ximeri M; Kalpadakis C; Gvazava G; Klaus M; Eliopoulos GD; Papadaki HA
Eur J Haematol; 2007 Dec; 79(6):531-8. PubMed ID: 17961177
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive properties of mesenchymal stem cells derived from bone marrow of patients with chronic myeloid leukemia.
Zhao ZG; Li WM; Chen ZC; You Y; Zou P
Immunol Invest; 2008; 37(7):726-39. PubMed ID: 18821219
[TBL] [Abstract][Full Text] [Related]
6. Impaired megakaryopoiesis in patients with chronic idiopathic neutropenia is associated with increased transforming growth factor beta1 production in the bone marrow.
Psyllaki M; Damianaki A; Gemetzi C; Pyrovolaki K; Eliopoulos GD; Papadaki HA
Br J Haematol; 2006 Sep; 134(6):624-31. PubMed ID: 16938119
[TBL] [Abstract][Full Text] [Related]
7. Pro-inflammatory bone marrow milieu in patients with chronic idiopathic neutropenia is associated with impaired local production of interleukin-10.
Koumaki V; Damianaki A; Ximeri M; Pontikoglou C; Axioti F; Spanoudakis M; Eliopoulos GD; Papadaki HA
Br J Haematol; 2006 Nov; 135(4):570-3. PubMed ID: 17054669
[TBL] [Abstract][Full Text] [Related]
8. Isolation of mesenchymal stem cells from human ligamentum flavum: implicating etiology of ligamentum flavum hypertrophy.
Chen YT; Wei JD; Wang JP; Lee HH; Chiang ER; Lai HC; Chen LL; Lee YT; Tsai CC; Liu CL; Hung SC
Spine (Phila Pa 1976); 2011 Aug; 36(18):E1193-200. PubMed ID: 21343850
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.
Bocelli-Tyndall C; Bracci L; Spagnoli G; Braccini A; Bouchenaki M; Ceredig R; Pistoia V; Martin I; Tyndall A
Rheumatology (Oxford); 2007 Mar; 46(3):403-8. PubMed ID: 16920750
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells.
Puissant B; Barreau C; Bourin P; Clavel C; Corre J; Bousquet C; Taureau C; Cousin B; Abbal M; Laharrague P; Penicaud L; Casteilla L; Blancher A
Br J Haematol; 2005 Apr; 129(1):118-29. PubMed ID: 15801964
[TBL] [Abstract][Full Text] [Related]
11. Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis.
Kastrinaki MC; Sidiropoulos P; Roche S; Ringe J; Lehmann S; Kritikos H; Vlahava VM; Delorme B; Eliopoulos GD; Jorgensen C; Charbord P; Häupl T; Boumpas DT; Papadaki HA
Ann Rheum Dis; 2008 Jun; 67(6):741-9. PubMed ID: 17921184
[TBL] [Abstract][Full Text] [Related]
12. TGF-β1 regulates differentiation of bone marrow mesenchymal stem cells.
Zhao L; Hantash BM
Vitam Horm; 2011; 87():127-41. PubMed ID: 22127241
[TBL] [Abstract][Full Text] [Related]
13. The characteristics and immunoregulatory functions of regulatory dendritic cells induced by mesenchymal stem cells derived from bone marrow of patient with chronic myeloid leukaemia.
Zhao ZG; Xu W; Sun L; Li WM; Li QB; Zou P
Eur J Cancer; 2012 Aug; 48(12):1884-95. PubMed ID: 22129888
[TBL] [Abstract][Full Text] [Related]
14. Effects of transforming growth factor-beta 1 and ascorbic acid on differentiation of human bone-marrow-derived mesenchymal stem cells into smooth muscle cell lineage.
Narita Y; Yamawaki A; Kagami H; Ueda M; Ueda Y
Cell Tissue Res; 2008 Sep; 333(3):449-59. PubMed ID: 18607632
[TBL] [Abstract][Full Text] [Related]
15. Activated T-lymphocytes with myelosuppressive properties in patients with chronic idiopathic neutropenia.
Papadaki HA; Stamatopoulos K; Damianaki A; Gemetzi C; Anagnostopoulos A; Papadaki T; Eliopoulos AG; Eliopoulos GD
Br J Haematol; 2005 Mar; 128(6):863-76. PubMed ID: 15755293
[TBL] [Abstract][Full Text] [Related]
16. Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling.
Longobardi L; O'Rear L; Aakula S; Johnstone B; Shimer K; Chytil A; Horton WA; Moses HL; Spagnoli A
J Bone Miner Res; 2006 Apr; 21(4):626-36. PubMed ID: 16598383
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory function of regulatory dendritic cells induced by mesenchymal stem cells.
Zhao ZG; Xu W; Sun L; You Y; Li F; Li QB; Zou P
Immunol Invest; 2012; 41(2):183-98. PubMed ID: 21936678
[TBL] [Abstract][Full Text] [Related]
18. Adipose derived stem cells (ASCs) isolated from breast cancer tissue express IL-4, IL-10 and TGF-β1 and upregulate expression of regulatory molecules on T cells: do they protect breast cancer cells from the immune response?
Razmkhah M; Jaberipour M; Erfani N; Habibagahi M; Talei AR; Ghaderi A
Cell Immunol; 2011; 266(2):116-22. PubMed ID: 20970781
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta.
Patel SA; Meyer JR; Greco SJ; Corcoran KE; Bryan M; Rameshwar P
J Immunol; 2010 May; 184(10):5885-94. PubMed ID: 20382885
[TBL] [Abstract][Full Text] [Related]
20. Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells.
Groh ME; Maitra B; Szekely E; Koç ON
Exp Hematol; 2005 Aug; 33(8):928-34. PubMed ID: 16038786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
